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The bacterial translocase mediates the translocation
and membrane integration of proteins. The integral
membrane proteins SecY and SecE are conserved core
subunits of the translocase. Previous cysteine-scanning
studies showed that the transmembrane segment (TMS)
3 of SecE contacts TMS 2 and 7 of SecY, and TMS 3 of
another SecE. We now demonstrate that SecE also con-
tacts TMS 10 of SecY. Combining all available cysteine-
scanning mutagenesis data, a three-dimensional model
has been built in which the positions of the helices that
form the central core of the bacterial translocase are
mapped. Remarkably, this model reveals that TMS 3 of
SecE is strongly tilted relative to SecY.
In bacteria, the translocase mediates the translocation of
proteins across and integration of membrane proteins into the
cytoplasmic membrane. Translocase consists of the membrane-
bound SecA and the integral membrane protein complex
SecYEG (for reviews see Refs. 1 and 2). SecY, SecE, and SecG
are membrane proteins that together form a heterotrimeric
complex (3, 4), which constitutes a high affinity binding site for
SecA (5). SecA is a large dimeric ATPase and drives the step-
wise translocation of precursor proteins (preproteins) across
the membrane by cycles of ATP binding and hydrolysis (6–8).
SecYEG can associate with another trimeric complex consist-
ing of SecD, SecF, and YajC that is required for efficient protein
export in vivo (9).
SecY and SecE are essential subunits of the translocase.
SecY harbors 10 transmembrane segments (TMSs)1 (see Fig.
1), whereas SecE has a single TMS in most bacteria. In Esch-
erichia coli, SecE contains three TMSs (see Fig. 1), but only the
conserved C-terminal domain including the third TMS is es-
sential for a functional translocase (10). SecY forms a stable
complex in the membrane with SecE that does not dissociate in
vivo (11) and is rapidly degraded by FtsH when uncomplexed
(12). Several domains of SecY and SecE have been suggested to
be in close contact. Mutations in the fourth cytoplasmic loop
(C4) of SecY (13) and C2 and TMS 3 of SecE (14) destabilize the
SecYE complex. Furthermore, specific combinations of prlA
(SecY) and prlG (SecE) mutations result in synthetic lethality
(15). Prl (for protein localization) is a class of mutants that
suppresses signal sequence defects, and the synthetic lethality
has been suggested to signify interactions between periplasmic
loop 1 (P1) of SecY and P2 of SecE and TMS 7 and 10 of SecY
and TMS 3 of SecE (15). Indeed, cysteine-directed cross-linking
studies demonstrated contacts between P1 of SecY and P2 of
SecE (16) and between TMS 3 of SecE and TMS 2 (17) and 7
(18) of SecY. Most of the conserved residues and prlA muta-
tions are clustered in TMS 2, 7, and 10 of SecY. Furthermore,
TMS 2 and 7 of Sec61, the yeast homologue of SecY, have been
implicated in the binding of the signal sequence of the prepro-
tein (19). These data strongly suggest a conserved core of the
translocase, consisting of TMS 2, 7, and 10 of SecY and TMS 3
of SecE that is involved in preprotein binding.
The SecYEG protomer is a dynamic complex that can orga-
nize into dimers and tetramers as revealed by electron micros-
copy, cysteine-scanning mutagenesis, sedimentation analysis,
and Blue Native (BN)-PAGE (18, 20–22). An activated state of
the SecA dimer (i.e. with a non-hydrolyzable ATP analog or
with a trapped preprotein intermediate) was found to be asso-
ciated with large ringlike SecYEG oligomers that could be
fitted to the size of a SecYEG tetramer (20). BN-PAGE demon-
strates that a trapped preprotein intermediate remains stably
associated with SecYEG dimers in the absence of SecA (22). A
chemical cross-linking study failed to demonstrate the pres-
ence of SecYEG oligomers, and it was suggested that such
forms represent aggregates formed as an artifact of the over-
production (23). However, cysteine-directed cross-linking dem-
onstrates that TMS 3 of SecE contacts a neighboring SecE
molecule (17, 18) within a dimeric SecYEG assembly even
when present at wild-type levels of the translocase (18),
whereas BN-PAGE indicates that the chemical cross-linking
interferes with the oligomerization of SecYEG (22). The exact
number of SecYEG subunits within the active oligomeric trans-
locase complex, however, is a topic of discussion.
A central question is how the SecYEG complex forms the
protein-conducting channel. To answer this, detailed informa-
tion is required about the molecular architecture of the
SecYEG complex. For this purpose, we have initiated a cys-
teine-scanning mutagenesis approach to probe sites of interac-
tion between SecY and SecE (17, 18). A model has been pre-
sented in which one face of TMS 3 of SecE stably interacts with
TMS 2 and 7 of SecY whereas the opposite face dynamically
interacts with TMS 3 of a neighboring SecE molecule that is
part of a separate SecYEG complex. The periodic reappearance
of the contacts suggests the presence of -helices as the sec-
ondary structure of the investigated transmembrane segments.
Based on the conserved residues and the high incidence of prlA
mutations in TMS 10 and observed synthetic lethal combina-
tions of prlA and prlG mutations, we expected also that TMS 10
of SecY is located in the core of the translocase in close vicinity
to SecE. Here, we indeed present evidence that TMS 3 of SecE
contacts TMS 10 of SecY periodically in space. Using our com-
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bined data, a three-dimensional model is presented that com-
piles all the identified contacts in the membrane between SecY
and SecE. This model reveals that TMS 3 of SecE is at the
contact interface between two SecYEG protomers and must be
strongly tilted to accommodate the various observed
interactions.
EXPERIMENTAL PROCEDURES
Materials—SecA (24), SecB (25), and proOmpA (26) were purified as
described. A stock solution of 80 mM Cu2(phenanthroline)3 (Sigma)
was prepared as described previously (17).
Plasmids—The plasmids used to overproduce SecYEG are listed in
Table I. Single cysteine mutations in TMS 10 were introduced by a
two-step polymerase chain reaction using plasmid pET607 (that allows
overexpression of a cysteine-less SecYEG with an N-terminal His6 tag
on SecY) as the template (17). Combining cysteine mutations in TMS 10
of SecY and TMS 3 of SecE was accompanied by the deletion of a ClaI
site between SecY and SecE to facilitate the screening for correct
mutants (17). All mutations were confirmed by complete sequence
analysis.
Bacterial Strains, Growth Conditions, and Membrane Vesicle Prep-
aration—Cell growth and isolation of inner membrane vesicles (IMVs)
were performed as described previously (17).
Cross-linking—For assays of disulfide bridge formation, IMVs
(1 mg/ml) were oxidized with 1 mM Cu2(phenanthroline)3 for 30 min at
37 °C. The oxidation reaction was quenched by the addition of 25 mM
neocuproine (Sigma). Samples were analyzed by 12% SDS-PAGE, West-
ern blotting onto polyvinylidene difluoride membranes (Amersham Bio-
sciences), and immunostaining using antibodies directed against SecY
or SecE (27).
Three-dimensional Modeling—The stretches of amino acids repre-
senting TMS 2, 7, and 10 of SecY and TMS 3 of SecE were constructed
as -helices with the HyperChem (Hypercube Inc.) software, exported
in the Brookhaven PDB file format, and subsequently visualized with
Weblab Viewer (Accelrys Inc.). The sites of contact between SecE and
SecY and a neighboring SecE were highlighted, and a model was built
by fitting the matching sites in the best possible way.
Miscellaneous Methods—Translocation reactions were essentially
performed as described (17) with the difference that the radioactive
label (125I) on proOmpA was replaced by a fluorescent label (fluorescein
maleimide), and translocated proOmpA was visualized with a Lumi-
Imager F1 (Roche, Basel, Switzerland).2 Protein concentrations were
determined with the DC protein assay (Bio-Rad) using bovine serum
albumin as a standard.
RESULTS
Construction, Expression, and Activity of Single Cysteine Mu-
tants of SecY—Unique cysteine mutations were introduced into
TMS 10 of SecY to investigate possible contacts with TMS 3 of
SecE as suggested by the synthetic lethality of combined prlA
and prlG mutants (15). The previously constructed SecE mu-
tants (L95C to T101C) (18) were located at the cytosolic side of
TMS 3. The new set of eight consecutive mutations (L406C to
I413C) of SecY covers at least two turns of the putative -hel-
ical structure of TMS 10. Sequence alignment and hydropho-
bicity analysis predict the same depth in the membrane as for
the SecE mutants (Fig. 1). The single cysteine SecY mutations
were placed into a cysteine-less SecYEG expression vector (17),
and the mutant SecYEG complexes were overproduced in
E. coli strain SF100. IMVs derived from these cells were ana-
lyzed for the SecY and SecE expression levels and proOmpA
translocation activity. The in vitro translocation assay moni-
toring the protease protection of the translocated proOmpA
was performed as described (17) except that fluorescein male-
imide-proOmpA was used instead of 125I-proOmpA,2 and visu-
alization of the fluorescent bands in the gel after SDS-PAGE
was done with a fluorescence imager. Cysteine-less SecYEG
was used as the control because it is indistinguishable from
wild-type SecYEG (17). The expression level of the SecYEG
mutants as analyzed by SDS-PAGE and Coomassie Brilliant
Blue staining were found to be similar to that of the overex-
pressed cysteine-less SecYEG complex with one exception.
IMVs harboring mutant SecY(I408C)EG showed a lower ex-
pression of SecY but not of SecE (data not shown) and a corre-
spondingly lower translocation activity (Fig. 2). Fig. 2 suggests
a slightly lower activity for mutant Y(V411C)EG. However, this
is not representative for SecY(V411C)EG as repeated experi-
ments show a translocation activity for the mutant that is
similar to wild-type SecYEG (data not shown). The cysteine
mutations did not produce a strong prl phenotype as none of the
mutants supported the translocation of 8-proOmpA, a prepro-
tein with a defective signal sequence that is translocated by
PrlA4 (Refs. 28 and 29 and data not shown), nor did they reveal
a significantly higher proOmpA translocation activity (Fig. 2).
TMS 10 of SecY Contacts TMS 3 of SecE at an -Helical
Interface—To identify possible sites of contact between SecY
and SecE, 56 pairs of cysteine mutations were constructed of




Plasmids containing an isopropyl--D-thiogalactoside-inducible trc promotor before a synthetic secYEG operon were used for the overexpression
of the Sec YEG complex.
Plasmid Relevant characteristic Mutation Source
pET607 Cysteine-less SecYEG in pET610 C329S (TGT3AGT); C385S (TGC3AGC) Ref. 17
SecY TMS 10 mutants in pET607:
pET2510 L406C L406C (CTG3TGT) This work
pET2511 L407C L407C (CTT3TGT) This work
pET2512 I408C I408C (ATC3TGT) This work
pET2513 V409C V409C (GTT3TGT) This work
pET2514 V410C V410C (GTT3TGT) This work
pET2515 V411C V411C (GTC3TGT) This work
pET2516 V412C V412C (GTG3TGT) This work
pET2517 I413C I413C (ATT3TGT) This work
SecE TMS 3 mutants in pET607:
pET2500 L95C L95C (CTG3TGT)a Ref. 18
pET2501 I96C I96C (ATT3TGT)a Ref. 18
pET2502 V97C V97C (GTG3TGT)a Ref. 18
pET2503 A98C A98C (GCT3TGT)a Ref. 18
pET2504 A99C A99C (GCG3TGT)a Ref. 18
pET2521 V100C V100C (GTT3TGT)a Ref. 18
pET2522 T101C T101C (ACC3TGC)a Ref. 18
a ClaI (ATCGAT3ATCGAC) between the SecY and SecE gene. The names of the double cysteine mutants are combined, e.g. pET2513/2522
contains SecY V409C and SecE T101C mutations.
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combinations in TMS 10 of SecY (at positions 406–413) and
TMS 3 of SecE (at positions 95–101). The overexpression level
and activity of the SecYEG complexes, which contain the SecE
cysteine mutations that are used in this study, have been
analyzed before and shown to be similar to wild-type SecYEG
(18). SecYEG IMVs of 49 pairs of cysteine mutations exhibited
normal levels of overexpression whereas the 7 combinations
with SecY I408C showed a lower SecY expression level (data
not shown). IMVs, corrected for the SecY level, were oxidized
with 1 mM Cu2(phenanthroline)3 and analyzed by SDS-PAGE
and immunoblotting using antibodies against SecY and SecE
(Fig. 3). Four cysteine combinations display reproducibly a
higher molecular mass band, which reacts with both antibodies
against SecY and SecE and corresponds to an expected SecY-
SecE cross-link. In particular the combinations SecY(V409C)-
SecE(T101C) and SecY(I413C)-SecE(V100C) yielded a strong
SecY-SecE cross-link. As shown previously for other identified
cross-links (18), oxidation of these cysteine mutant pairs re-
sulted in the inactivation of the protein translocation reaction,
whereas the activity was recovered after reduction with dithi-
othreitol (data not shown). Several other cysteine pairs, espe-
cially in combination with SecY I408C, show a faint band at the
position of the expected SecY-SecE cross-link (Fig. 3). These
bands are significantly weaker than those for the four cysteine
pairs mentioned above, did not stain with the SecE antibody,
and lacked apparent reproducibility. Therefore, we do not be-
lieve that these bands reflect clear contact points between SecY
and SecE. The cross-linking data could be modeled by assum-
ing an -helical contact interface between TMS 10 of SecY and
TMS 3 of SecE (Figs. 4 and 5).
Model for the Core of the SecYE Complex—To incorporate the
identified cross-links into a three-dimensional model, TMS 2
(Ala75–Ile92), 7 (Val274–Ala291), and 10 (Val397–Met414) of SecY
and TMS 3 (Leu95–Asp112) of SecE were built as -helices in
silico. Strikingly, TMS 7 and 10 of SecY contact the same side
of TMS 3 of SecE. However, the position on SecE (Val97) that
shows the strongest cross-linking reaction with TMS 7 of SecY
is located at a different depth in the membrane than the posi-
tions (Val100 and Thr101) that are the strongest contact sites to
TMS 10 of SecY. Only one model (Fig. 5) could explain all 13
observed transmembrane contacts (Refs. 17 and 18 and this
study). Remarkably, this model implies a strongly tilted SecE
helix surrounded by TMS 2, 7, and 10 of SecY. We therefore
conclude that TMS 3 of SecE is tilted relative to the surround-
ing transmembrane segments of SecY in the core of the
translocase.
DISCUSSION
To fully understand the mechanism of translocation and
membrane insertion of proteins, detailed structural informa-
tion of the translocase is essential. The highest level of struc-
tural information can be derived from x-ray crystallography.
However, crystallization of membrane proteins is very difficult
to accomplish. This is in particular a major challenge with the
SecYEG complex as it needs to interact with the soluble SecA
protein to form a functional translocase. Recently, two-dimen-
sional crystals of SecYEG have been produced from which a 9-Å
projection structure was calculated, but the structural infor-
mation in this projection of SecYEG is limited as it is not
FIG. 1. Membrane topology of E. coli SecY and SecE. The black diamonds represent endogenous cysteine residues in SecY that were
replaced by serine residues. The residues that were replaced by cysteine are depicted as black circles.
FIG. 2. Expression levels and activities of SecYEG complexes
harboring a cysteine mutation in TMS 10 of SecY. IMVs contain-
ing overexpressed SecYEG mutants were analyzed by: A, a Coomassie
Brilliant Blue stained gel showing the levels of His-tagged SecY over-
expression. B, in vitro translocation of proOmpA. SecY, proOmpA, and
OmpA are indicated by arrows.
Tilted SecE36642
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possible to assign the helices at this resolution (21). An alter-
native approach for obtaining structural information is cys-
teine-scanning mutagenesis, a technique that can be used to
map the sites of contact between the transmembrane segments
in membrane proteins. An important advantage of this tech-
nique is that structural information is obtained from the func-
tional, membrane-embedded proteins, and observed sites of
interaction can be further exploited to obtain information on
the dynamics of the proteins involved. We have used this tech-
nique to reveal the sites of interaction between SecY and SecE,
both essential components of the protein-conducting channel.
In this study, we show that TMS 3 of SecE contacts TMS 10 of
SecY. Furthermore, we present a three-dimensional model of
the SecYE core based on the combined cross-linking data.
We have identified multiple sites of contact between SecY
and SecE and between two neighboring SecE molecules.
Using pairs of cysteine mutations, sites of contact were iden-
tified between TMS 3 of SecE and TMS 2 (S105C-I82C;
L108C-F78C; L108C-A79C) (17) and TMS 7 (V97C-P276C;
V100C-A280C; T101C-A280C) (18) of SecY. Here, we show
that TMS 3 of SecE also contacts TMS 10 of SecY (V97C-
V410C; V97C-I413C; V100C-I413C; T101C-V409C) (Fig. 3).
All cross-links reappear periodically, consistent with an
-helical structure of these transmembrane segments (Figs. 4
and 5A). Oligomeric forms of SecYEG were revealed by co-
valently linked SecE dimers when cysteines are introduced at
the positions of Ala99, Leu106, and Gly110 in TMS 3 (17, 18).
These contacts also display spatial periodicity, indicating an
-helical interface that covers the entire span of the mem-
brane. Furthermore, the SecE dimer interface is mapped
opposite to the SecY-SecE contacts (Fig. 5B).
prl mutations in SecY and SecE result in thermally induced
destabilization of the SecY-SecE interaction (30). The current
study shows that the positions of known prlA mutations in
TMS 10 are directed away from the SecY-SecE interface (Fig.
4). This phenomenon has also been observed previously for
TMS 2 and 7 of SecY (18). This implies that the effect on the
SecY-SecE interaction caused by prl mutations must be indi-
rect, probably mediated by a local disturbance of the structure
or helical packing. The mutation I408C in SecY resulted in
lowered expression levels, but the translocation activity was
found to be comparable with cysteine-less SecYEG when cor-
rected for the reduced SecY levels (Fig. 2). Ile408 is a hot spot for
known prl mutations and thus sensitive to mutational changes.
However, I408C did not yield a strong prl phenotype as assayed
by translocation of 8-proOmpA (data not shown).
Strikingly, the suggested contact interfaces of TMS 3 of SecE
to TMS 7 and 10 of SecY are overlapping. An effort to fit all
observed inner membrane cross-links resulted in the model
shown in Fig. 5. For this, TMS 2, 7, and 10 of SecY and TMS 3
of SecE were modeled as -helices and arranged such that all
identified sites of contact could be accommodated. Extensive
modeling and probing of the different contacts resulted in only
one model that met the set criteria. Other models could not fit
the complete set of identified cross-links or even generate ex-
pected sites of contact that were not observed experimentally.
Our model revealed a tilted TMS 3 of SecE relative to the
surrounding TMS 2, 7, and 10 of SecY. Furthermore, a tilted
helix implies a crossed contact interface between two SecYE
FIG. 3. Identification of the sites of contact between TMS 10 of SecY and TMS 3 of SecE. Eight consecutive unique cysteine mutations
in SecY TMS 10 were co-expressed with seven cysteine mutations in SecE TMS 3 and wild-type SecG. IMVs containing the mutant SecYEG
complexes were oxidized with 1 mM Cu2(phenanthroline)3 and analyzed by 12% SDS-PAGE and immunoblotting using antibodies against SecY
and SecE. Mutant SecY(P276C)E(V97C)G that gives a cross-link between TMS 7 of SecY and TMS 3 of SecE was included as a control (18). The
bands representing SecY (Y) and SecY-SecE cross-link (Y-E) (50 kDa) are indicated by arrows.
FIG. 4. Schematic representation of the contact interface be-
tween TMS 10 of SecY and TMS 3 of SecE. Schematic top view of
TMS 10 of SecY and TMS 3 of SecE, which are depicted as helices.
Cysteine-substituted residues involved in SecY-SecE cross-linking are
shown as closed circles and connected by a line. Sites of known prlA
mutations are displayed as open circles.
Tilted SecE 36643
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FIG. 5. Three-dimensional models of the SecYE complex. Side view of helices representing TMS 2, 7, and 10 of SecY and TMS 3 of SecE.
A, monomeric view; B, dimeric view. SecY and SecE helices are indicated and displayed in white and gray, respectively. Colored patches and lines
are used to specify the residues that are involved in contacts between TMS 3 of SecE and the following helices of SecY: TMS 2 (green), TMS 7 (blue),
and TMS 10 (yellow). TMS 7 and 10 of SecY can be cross-linked to the same residues of SecE. Therefore, the residues involved are colored only
according to their strongest contacts (i.e. SecE Val97 in blue; Val100 and Thr101 in yellow). Sites of contact between neighboring SecE molecules are
depicted in red patches and connected by red lines. Efficiency of cross-linking is categorized in strong (thick lines) and weak (thin lines).
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molecules and the presence of an optimal point of contact
because the formation of a SecYE dimer involves TMS 3 of SecE
(Fig. 5B). Indeed, Leu106 of SecE has been observed as an
optimal point of contact as the SecE-SecE cross-linking effi-
ciency for the L106C mutation is significantly higher than for
the surrounding A99C and G110C (18). We believe that our
model is a correct representation of the core of the translocase
because: 1) it accommodates all 13 identified inner membrane
contacts; 2) periodically re-appearing contacts have been found
for every helix-helix interface; and 3) it predicts no additional
strong cross-links other than those already observed for the
cysteine combinations we have tested. Strikingly, a recent
three-dimensional reconstruction of the SecYEG dimer from
two-dimensional crystals reveals the presence of two highly
tilted helices at the SecYEG contact interface (31). Because
SecE has been mapped at this interface, we propose that these
helices represent the SecE dimer contact interface (17, 18).
The dynamics of the identified interactions within the func-
tional translocase have been investigated before (17, 18). The
formation of thiol-stabilized interactions in the interface be-
tween TMS 3 of SecE and TMS 7 of SecY and another TMS 3 of
SecE inhibits preprotein translocation reversibly (17, 18). This
is also observed for the identified SecY TMS 10–SecE TMS 3
contacts (data not shown). These disulfide bonds can, however,
also be formed between SecY and SecE (17, 18) and even much
more efficiently between neighboring SecE molecules (17) dur-
ing an active cycle of preprotein translocation. Therefore, tran-
sient flexibility and conformational changes within the integral
membrane domain of the translocase appear essential for its
function. The current data will facilitate future attempts to
resolve the structure of the translocase and to study its dy-
namic nature during preprotein translocation.
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